Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study

Completed

Conditions studied: Hyperlipidemia, Pregnancy

In brief

The purpose of this study is to ascertain lipid profiles during pregnancy, specifically during the 24-28 week gestation and again near term at 36 weeks gestation. The research team are investigating whether lipid profiles can predict adverse maternal and neonatal outcomes.

Key facts

Study ID

NCT05535660

Run by

Icahn School of Medicine at Mount Sinai

People needed

111

Starts

2022-07-29

Expected to finish

2024-08-05

Last updated by the study team

2024-11-07

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Singleton pregnancy
• Ages 18-45
• Presentation to prenatal care by the 2nd trimester
• Prenatal care at Mount Sinai Hospital
• Anticipated delivery at Mount Sinai Hospital

You may not qualify if…

• Multiple gestations
• Preexisting hyperlipidemia
• Preexisting diabetes
• Delayed presentation to prenatal care after the 2nd trimester 5. Prenatal care or delivery outside of Mount Sinai Health System

Where it is running

• Mount Sinai OBGYN Faculty Practice Associates — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.